EndoQuest Robotics, Inc., a pioneering leader in endoluminal robotic surgical technology, today announced that enrollment in ...
Stories by SWNS on MSN
Low iron was my only symptom – then doctors found stage 3 bowel cancer
A mum was diagnosed with stage three bowel cancer after her low iron levels were flagged when she tried to donate blood.
Johnson & Johnson announced that the US Food and Drug Administration (FDA) has granted De Novo authorization for the Ottava Robotic Surgical System, the world’s first table-integrated soft tissue ...
A 76-year-old woman diagnosed with jejunal adenocarcinoma, a rare cancer of the small intestine, underwent a complex surgery ...
The FDA grants marketing authorization for Johnson & Johnson’s Ottava robotic surgery system for upper abdominal procedures.
J&J received FDA authorization for OTTAVA robotic surgical system, enabling commercial launch for surgery procedures in the US. Read more.
A MUM whose low iron levels were flagged when she tried to donate blood was shocked to discover it was a sign of bowel cancer ...
J&J MedTech unveiled its long-awaited Ottava with FDA de novo authorization for the first table-integrated soft-tissue ...
Laura Jackson, 39, said she did not have many symptoms of bowel cancer - including blood in her stool - and had put down her ...
The U.S. Food and Drug Administration (FDA) has granted De Novo authorization for Johnson & Johnson’s OTTAVA™ Robotic ...
While not disclosing a specific launch timeframe, with de novo clearance in hand, J&J initially plans to launch Ottava with “select customers”.
Johnson & Johnson (JNJ) wins FDA's De Novo authorization for the company’s soft tissue robotic system, Ottava. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results